- AMRN -0.87%
Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript
Yahoo Finance · 1 day ago
Open | 0.8946 |
High | 0.9340 |
Low | 0.8911 |
Mkt Cap | 373.89M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 0.9180 |
52 Wk. Low | 0.6500 |
52 Wk. High | 1.4900 |
Related stocks
Biopharmaceutical company
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 56.52M | 34.30% ▼ |
Net Income | -9.95M | - |
Diluted EPS | -0.02 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.03 | - |
Q1 2024 | -$0.03 | -$0.02 |
Q4 2023 | -$0.03 | -$0.01 |
S&P 500^GSPC | 5,127.79+63.59 (+1.26%) |
Dow 30^DJI | 38,675.68+450.02 (+1.18%) |
Nasdaq^IXIC | 16,156.33+315.37 (+1.99%) |
400.87+0.07% | |
Bitcoin USDBTC-USD | 63,607.05+3.05% |
603,000.00-0.56% |